SCHEMBL6906558

SCHEMBL6906558

NC1(N)C=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)N1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ CDA P32320 6/20 0.44
▸ SLC28A1 O00337 1/20 0.44
▸ SLC28A2 O43868 1/20 0.44
▸ SLC29A1 Q99808 1/20 0.44
▸ SLC28A3 Q9HAS3 1/20 0.44
▸ MTOR P42345 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ MDM2 Q00987 1/20 0.42
▸ NCOA1 Q15788 1/20 0.42
▸ NCOA3 Q9Y6Q9 1/20 0.42
▸ GMNN O75496 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ DNMT1 P26358 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3630509 1.00 LMNA (0.45) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL25188377 0.88 CDA (0.43) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL31436719 0.87 CDA (0.42) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL10903345 0.87 CDA (0.42) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL29845228 0.85 CDA (0.41) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL4751008 0.85 LMNA (0.42) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL17440122 0.85 CDA (0.41) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL27845966 0.85 CDA (0.41) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL22978939 0.85 CDA (0.41) LMNASMN1; SMN2ALDH1A1POLBCDA
SCHEMBL10903331 0.85 LMNA (0.42) LMNASMN1; SMN2ALDH1A1POLBCDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689756-B2 VIA CATHETER COMPRISING ANTIMICROBIAL AGENT AND SECOND CATHETER FOR WITHDRAWING FLUID; FOR TREATING INFECTION OR NEOPLASM OF CEREBROSPINAL TISSUE INTEGRA LIFESCIENCES CORPORATION 2004-02-10 — — US disclosed
US-20030022879-A1 Treatment of neurological disease INTEGRA LIFESCIENCES CORPORATION 2003-01-30 — — US disclosed
Send feedback